In
this study, we synthesized and characterized a silicon phthalocyanine
substituted with 3-hydroxypyridin-2-thione (
SiPc-HDACi
), designed to be a chemophotodynamic therapy agent acting as a histone
deacetylase inhibitor, and we determined its photophysical, photochemical,
and photobiological properties. Next, we evaluated its anticancer
efficacy on MCF-7, double positive and MDA-MB-231, triple negative
breast cancer cell lines, as well as on a healthy human endothelial
cell line (HUVEC). Our results indicate that
SiPc-HDACi
can target nucleoli of cells, effectively inducing apoptosis while
promoting cell cycle arrest thanks to its high singlet oxygen yield
and its histone deacetylase downregulating properties, suggesting
a powerful anticancer effect on breast cancer
in vitro
. Our further studies will be conducted with primary breast cancer
cell culture to give a better insight into the anticancer mechanism
of the compound.
3-Hydroxypyridin-2-thione bearing zinc and indium phthalocyanine derivatives, as photosensitizer agents have been synthesized and evaluated for their anti-cancer efficacy on two breast cancer cell lines, MDA-MB-231 and MCF-7 as well as a human endothelial cell line, HUVEC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.